XML 45 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidated Statements of Equity - 9 months ended Sep. 30, 2015 - USD ($)
Total
Total NeoStem, Inc. Shareholders' Equity [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Beginning Balance (shares) at Dec. 31, 2014     10,000 36,783,857          
Beginning Balance at Dec. 31, 2014 $ 58,073,789 $ 58,514,836 $ 100 $ 36,784 $ 350,428,903 $ 1,329 $ (291,246,538) $ (705,742) $ (441,047)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (47,782,363) (47,689,106)         (47,689,106)   (93,257)
Unrealized gain on marketable securities (451) (451)       (451)      
Share-based compensation (in shares)       811,835          
Share-based compensation 8,568,605 8,568,605   $ 812 8,567,793        
Stock Issued During Period, Shares, New Issues       17,901,548          
Net proceeds from issuance of common stock 36,136,839 36,136,839   $ 17,901 36,118,938        
Proceeds from exercise of options 0                
Change in Ownership in Subsidiary 0 (101,367)     (101,367)       101,367
Ending Balance at Sep. 30, 2015 $ 54,996,419 $ 55,429,356 $ 100 $ 55,497 $ 395,014,267 $ 878 $ (338,935,644) $ (705,742) $ (432,937)
Ending Balance (shares) at Sep. 30, 2015     10,000 55,497,240